Cyclin D1, a protein that helps push a replicating cell through the cell cycle also mediates the processing and generation of mature microRNA (miRNA), finds a new study.
The research suggests that a protein strongly implicated in human cancer also governs the non-protein-coding genome.
Women and Cancer
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.
Advertisement
The non-coding genome, previously referred to as junk DNA, makes up most of the human genome, and unlike the coding genome, varies greatly between species.
"In addition to its role in regulating the cell cycle, cyclin D1 induces Dicer and thereby promotes the maturation of miRNA," lead researcher Richard Pestell, M.D., Ph.D., Director of the Kimmel Cancer Center at Thomas Jefferson University and Chair of the Department of Cancer Biology, said.
![Skin Cancer Prevention Campaign in Brazil]( "Skin Cancer Prevention Campaign in Brazil")
A nationwide campaign against skin cancer has been launched by the health authorities and Brazilian Dermatology Society
Dicer is a protein that converts inactive hairpin-structured microRNA precursors into their active single stranded form.
"The work supports the idea that cancer-causing proteins like cyclin D1 may drive cancer progression in part via miRNA biogenesis," he said.
Using antisense RNA, Dr. Pestell's group was the first to show that cyclin D1 drives mammary tumor growth in vivo.
In prior work, they showed that cyclin D1 regulates the non coding genome, and that the non-coding genome, in turn, regulates expression of cyclin D1.
Furthermore, the group showed that many cancer patients encode a form of cyclin D1 that evades negative feedback from the non coding genome.
These attenuating feedback loops between the non coding and coding genome may be a common theme in cancer and other biological processes.
In the current study, the group sought to investigate the mechanism by which cyclin D1 regulates the biogenesis of non coding miRNA.
Dr. Pestell and colleagues developed transgenic mice that could induce cyclin D1 expression in the breast and examined cells with cyclin D1 gene deleted.
The researchers noticed that cells lacking cyclin D1 produced less of the miRNA-processing protein, Dicer, and therefore had reduced levels of mature miRNA.
The study is published in the journal Nature Communications.
Source: ANI
Skin Cancer Prevention Campaign in Brazil
A nationwide campaign against skin cancer has been launched by the health authorities and Brazilian Dermatology Society
Advertisement
Dicer is a protein that converts inactive hairpin-structured microRNA precursors into their active single stranded form.
"The work supports the idea that cancer-causing proteins like cyclin D1 may drive cancer progression in part via miRNA biogenesis," he said.
Using antisense RNA, Dr. Pestell's group was the first to show that cyclin D1 drives mammary tumor growth in vivo.
In prior work, they showed that cyclin D1 regulates the non coding genome, and that the non-coding genome, in turn, regulates expression of cyclin D1.
Furthermore, the group showed that many cancer patients encode a form of cyclin D1 that evades negative feedback from the non coding genome.
These attenuating feedback loops between the non coding and coding genome may be a common theme in cancer and other biological processes.
In the current study, the group sought to investigate the mechanism by which cyclin D1 regulates the biogenesis of non coding miRNA.
Dr. Pestell and colleagues developed transgenic mice that could induce cyclin D1 expression in the breast and examined cells with cyclin D1 gene deleted.
The researchers noticed that cells lacking cyclin D1 produced less of the miRNA-processing protein, Dicer, and therefore had reduced levels of mature miRNA.
The study is published in the journal Nature Communications.
Source: ANI
Research Indicates Cancer Risk Increases as Baby Boomers Age
Research indicates that as baby boomers age, the risk of cancer increases accordingly.
Advertisement
 Cancer Growth Could be Blocked by New TechniqueA new mechanism involving a signaling protein and its receptor that could block the formation of new blood vessels and cancer growth has been demonstrated by researchers. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
The scientists discovered that when the stem cells in the hair follicle are made softer, they have a higher chance of growing hair.
A combinatorial therapy provided promising beneficial results among people with ischemic stroke.
In Parkinson's disease patients voice disorders are quite common. A new combination therapy had greater effects on the voice.
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.